Home » Topics » Conferences

Conferences
RSS

Ensemble Therapeutics describes Ensemblins

Sep. 15, 2010

GNE-A shows preclinical potential as anticancer agent

Sep. 15, 2010

Clinical data on sevuparin in healthy adults support evaluation in phase II trial in malaria

Sep. 14, 2010

Omecamtiv mecarbil improves left atrial contractility in healthy males

Sep. 14, 2010

New partial 5-HT3 receptor agonist described for treatment of IBS

Sep. 14, 2010

MEDI-578 has analgesic effects in rat model of inflammatory pain

Sep. 14, 2010

New dual mTOR/PI3K-alpha inhibitor PF-04979064 may advance to clinic as anticancer agent

Sep. 14, 2010

Vardenafil improves exercise capacity in phase III trial in subjects with PAH

Sep. 14, 2010

New histamine H4 receptor ligand VUF-11488 to be tested in inflammation models

Sep. 13, 2010

Intranasal desmopressin ineffective in relieving renal colic pain

Sep. 13, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...